Beta-blockers do not lower mortality after myocardial infarction with preserved ejection fraction
1. In this randomized controlled trial, long-term beta-blockers did not impact all-cause mortality...
Read MoreApr 25, 2024
1. In this randomized controlled trial, long-term beta-blockers did not impact all-cause mortality...
Read MoreApr 24, 2024
1. In this randomized controlled trial, semaglutide was more effective in reducing heart...
Read MoreApr 23, 2024
1. Mitoxantrone enhances five-year event-free survival over liposomal daunorubicin in MRD-guided...
Read MoreApr 16, 2024
1. When compared to upfront surgery, neoadjuvant chemotherapy using mFOLFOX or CAPOX did not...
Read MoreApr 16, 2024
1. The hazard ratio for recurrence or death comparing sentinel node biopsy only to completion...
Read MoreApr 12, 2024
1. The 3-month symptomatic venous thromboembolism rate was 0.7% in patients with TRiP(cast) score...
Read MoreApr 11, 2024
1. Overall vaccine efficacy ranged from 83.1% to 86.6% during the 10-year period. 2. Detectable...
Read MoreApr 10, 2024
1. Intravascular imaging-guided PCI significantly reduces target lesion failure compared to...
Read MoreApr 9, 2024
1. Roughly 65% of the cancer medication budget is allocated to treatments that provide improvement...
Read MoreApr 9, 2024
1. The pathological response rate had an OR of 3.16 when comparing neoadjuvant dual vs single...
Read MoreApr 8, 2024
1. Patients randomized to receive the paravertebral block (PVB) and erector spinae plane block...
Read MoreApr 6, 2024
1. In this randomized controlled trial, omalizumab was superior to placebo in increasing the...
Read MoreApr 6, 2024
1. This retrospective study found that the use of medications for alcohol use disorder (MAUD)...
Read MoreApr 4, 2024
1. In this cohort study, neutralizing autoantibodies against interleukin-23 (anti-IL-23) were...
Read MoreApr 3, 2024
1. In this prospective study, patients with carotid artery stenosis with microplastics and...
Read MoreApr 3, 2024
1. 18-month recurrence-free survival was significantly greater in the combination therapy group...
Read MoreApr 2, 2024
1. Pazopanib did not improve disease-free survival in post-metastasectomy renal cell carcinoma...
Read MoreApr 2, 2024
1. The overall survival had a significant hazard ratio (0.65) when comparing neoadjuvant...
Read MoreMar 29, 2024
Click here to read this study in JAMA Network Open. ©2024 2 Minute Medicine, Inc. All rights...
Read MoreMar 28, 2024
1. Post-ERCP pancreatitis was more common in the indomethacin alone group compared to indomethacin...
Read More